Geneos Wealth Management’s John Hancock Multifactor Mid Cap ETF JHMM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.5K | Hold |
540
| – | – | ﹤0.01% | 1535 |
|
|
2026
Q1 | $36.2K | Hold |
540
| – | – | ﹤0.01% | 1546 |
|
|
2025
Q4 | $35.4K | Hold |
540
| – | – | ﹤0.01% | 1528 |
|
|
2025
Q3 | $34.9K | Hold |
540
| – | – | ﹤0.01% | 1512 |
|
|
2025
Q2 | $33K | Hold |
540
| – | – | ﹤0.01% | 1780 |
|
|
2025
Q1 | $30.9K | Hold |
540
| – | – | ﹤0.01% | 1721 |
|
|
2024
Q4 | $32.3K | Sell |
540
-92
| -15% | -$5.67K | ﹤0.01% | 1511 |
|
|
2024
Q3 | $38K | Buy |
632
+92
| +17% | +$5.26K | ﹤0.01% | 1295 |
|
|
2024
Q2 | $29.7K | Hold |
540
| – | – | ﹤0.01% | 1240 |
|
|
2024
Q1 | $31K | Buy |
540
+140
| +35% | +$7.52K | ﹤0.01% | 1233 |
|
|
2023
Q4 | $21.1K | Hold |
400
| – | – | ﹤0.01% | 1332 |
|
|
2023
Q3 | $18.9K | Hold |
400
| – | – | ﹤0.01% | 1386 |
|
|
2023
Q2 | $19.9K | Hold |
400
| – | – | ﹤0.01% | 1376 |
|
|
2023
Q1 | $19.2K | Sell |
400
-1,073
| -73% | -$52.1K | ﹤0.01% | 1362 |
|
|
2022
Q4 | $68.6K | Hold |
1,473
| – | – | ﹤0.01% | 946 |
|
|
2022
Q3 | $62K | Sell |
1,473
-330
| -18% | -$15.5K | ﹤0.01% | 955 |
|
|
2022
Q2 | $80K | Buy |
1,803
+131
| +8% | +$6.34K | ﹤0.01% | 1097 |
|
|
2022
Q1 | $87K | Buy |
1,672
+199
| +14% | +$10.4K | ﹤0.01% | 1139 |
|
|
2021
Q4 | $81K | Hold |
1,473
| – | – | ﹤0.01% | 1251 |
|
|
2021
Q3 | $77K | Hold |
1,473
| – | – | ﹤0.01% | 1273 |
|
|
2021
Q2 | $77K | Hold |
1,473
| – | – | ﹤0.01% | 1276 |
|
|
2021
Q1 | $75K | Hold |
1,473
| – | – | ﹤0.01% | 1424 |
|
|
2020
Q4 | $72K | Hold |
1,473
| – | – | ﹤0.01% | 1277 |
|
|
2020
Q3 | $54K | Hold |
1,473
| – | – | ﹤0.01% | 1216 |
|
|
2020
Q2 | $50K | Hold |
1,473
| – | – | ﹤0.01% | 1213 |
|
|
2020
Q1 | $41K | Hold |
1,473
| – | – | ﹤0.01% | 1204 |
|
|
2019
Q4 | $57K | Hold |
1,473
| – | – | ﹤0.01% | 1185 |
|
|
2019
Q3 | $53K | Sell |
1,473
-1,500
| -50% | -$54.7K | ﹤0.01% | 1145 |
|
|
2019
Q2 | $108K | Hold |
2,973
| – | – | 0.01% | 879 |
|
|
2019
Q1 | $104K | Buy |
2,973
+345
| +13% | +$11.7K | 0.01% | 853 |
|
|
2018
Q4 | $79K | Hold |
2,628
| – | – | 0.01% | 911 |
|
|
2018
Q3 | $95K | Buy |
2,628
+400
| +18% | +$14.5K | 0.01% | 903 |
|
|
2018
Q2 | $77K | Sell |
2,228
-400
| -15% | -$13.9K | 0.01% | 874 |
|
|
2018
Q1 | $90K | Hold |
2,628
| – | – | 0.01% | 792 |
|
|
2017
Q4 | $89K | Hold |
2,628
| – | – | 0.01% | 785 |
|
|
2017
Q3 | $84K | Buy |
2,628
+1,900
| +261% | +$59.7K | 0.01% | 757 |
|
|
2017
Q2 | $22K | Hold |
728
| – | – | ﹤0.01% | 1234 |
|
|
2017
Q1 | $22K | Hold |
728
| – | – | ﹤0.01% | 1203 |
|
|
2016
Q4 | $20K | Hold |
728
| – | – | ﹤0.01% | 1185 |
|
|
2016
Q3 | $20K | Hold |
728
| – | – | ﹤0.01% | 1134 |
|
|
2016
Q2 | $19K | Hold |
728
| – | – | ﹤0.01% | 1135 |
|
|
2016
Q1 | $18K | Buy |
+728
| New | +$17.6K | ﹤0.01% | 1126 |
|
Other funds holding JHMM
Geneos Wealth Management's JHMM Position: Q2 2026 in Review
Geneos Wealth Management held its John Hancock Multifactor Mid Cap ETF (JHMM) position steady in Q2 2026 at 540 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1535.
Geneos Wealth Management first reported a position in JHMM in Q1 2016 and has held it in 42 quarters since. The position peaked at $108K in Q2 2019. 296 funds tracked by Wall St. Rank hold JHMM as of Q2 2026.
- Geneos Wealth Management held 540 shares of John Hancock Multifactor Mid Cap ETF worth $40.5K as of Q2 2026.
- Geneos Wealth Management left its John Hancock Multifactor Mid Cap ETF share count unchanged in Q2 2026.
- John Hancock Multifactor Mid Cap ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1535 holding.
- Geneos Wealth Management first reported a position in John Hancock Multifactor Mid Cap ETF in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's John Hancock Multifactor Mid Cap ETF position peaked at $108K in Q2 2019.
- 296 funds tracked by Wall St. Rank held John Hancock Multifactor Mid Cap ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.